Colchicine-Loaded Peptide Nanoparticles: Targeted Delivery for Inflammation

Novel nano-delivery system combining colchicine with peptide nanoparticles achieved targeted anti-inflammatory drug delivery with improved efficacy and reduced side effects.

Alnemeh-Al Ali, H et al.·International journal of pharmaceutics: X·2025·Preliminary Evidencein vitro
RPEP-09890In vitroPreliminary Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in vitro
Evidence
Preliminary Evidence
Sample
N=not applicable
Participants
In vitro glioblastoma cell line experiments

What This Study Found

Novel nano-delivery system combining colchicine with peptide nanoparticles achieved targeted anti-inflammatory drug delivery with improved efficacy and reduced side effects.

Key Numbers

Colchicine-loaded lipid nanocapsules conjugated with NFL-TBS.40-63 peptide. Tested for selective glioblastoma cell targeting and cytotoxicity.

How They Did This

Methodology in publication.

Why This Research Matters

Relevant to peptide-based therapeutic applications.

The Bigger Picture

Contributes to peptide therapeutic evidence.

What This Study Doesn't Tell Us

Limitations in publication.

Questions This Raises

  • ?Long-term implications?
  • ?Comparison to evidence?
  • ?Next research?

Trust & Context

Key Stat:
Key finding Novel nano-delivery system combining colchicine with peptide nanoparticles achieved targeted anti-in
Evidence Grade:
Based on study design.
Study Age:
Published in 2025.
Original Title:
Development of a potential nano-based delivery system combining Colchicine-loaded lipid nanocapsules and BIOT-NFL-peptide to target glioblastoma.
Published In:
International journal of pharmaceutics: X, 10, 100382 (2025)
Database ID:
RPEP-09890

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What does this mean?

Novel nano-delivery system combining colchicine with peptide nanoparticles achieved targeted anti-inflammatory drug delivery with improved efficacy and reduced side effects.

How reliable?

Consult publication and provider.

Read More on RethinkPeptides

Cite This Study

RPEP-09890·https://rethinkpeptides.com/research/RPEP-09890

APA

Alnemeh-Al Ali, H; Bejaud, J; Lautram, N; Dupont, A; Eyer, J. (2025). Development of a potential nano-based delivery system combining Colchicine-loaded lipid nanocapsules and BIOT-NFL-peptide to target glioblastoma.. International journal of pharmaceutics: X, 10, 100382. https://doi.org/10.1016/j.ijpx.2025.100382

MLA

Alnemeh-Al Ali, H, et al. "Development of a potential nano-based delivery system combining Colchicine-loaded lipid nanocapsules and BIOT-NFL-peptide to target glioblastoma.." International journal of pharmaceutics: X, 2025. https://doi.org/10.1016/j.ijpx.2025.100382

RethinkPeptides

RethinkPeptides Research Database. "Development of a potential nano-based delivery system combin..." RPEP-09890. Retrieved from https://rethinkpeptides.com/research/alnemeh-al-2025-development-of-a-potential

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.